Today, almost all
Indian pharmaceutical establishments are seeing great worth in committing their
time and resources in research and development (R&D) of therapeutic drug
and in their discovery. However, major pharmaceutical companies began to invest
in Research and Development in India and new Pharmaceutical Formulations in India as early as three decades ago, in other words,
in the '80s.
What sets a big,
pioneering pharmaceutical company apart from the rest of the lot is
its capacity to develop generic medicines as well as scientifically intricate
remedies, with the help of their highly skilled teams working together in
formulations, processes and analytics. Finally, it all comes down to the
ability of the Pharma company to deliver the drug within set time limits, at
competitive prices and, of course, without compromising on the standard quality
of the final products.
Among the major
pharmaceutical establishments in India, some of them have more than fifteen
hundred scientific research professionals operating in numerous research &
development hubs. These research scientists are known to work with the latest
and the most advanced technological equipment for their research. The
scientists possess all the expertise to develop the latest in generic drug,
complex tech intensive offerings, Active Pharmaceutical Ingredients (known
around the world as APIs), newer chemical entities and novel drug-delivery systems.
A very important
aspect that major pharmaceutical companies have mastered is developing and
nurturing a work ecosphere where their scientists can work side by side with
their business development professionals. This symbiosis enables the scientists
to generate innovative conceptions that cater to the market needs as well as
for activities across various other therapeutic domains.
With Contract Research in India, Pharma companies across the country get a
tremendous opportunity to give contracts to independent researching
organisations which assist them in drug discovery and development. These
unique, innovative and mutual relationships have earned pharmaceutical
establishments rich dividends in terms of business, as well as helping them
attain enviable reputation for their deliverance of high standards of quality,
original solutions and competence.
